Frenckner B, Ehrén H, Palmér K
Department of Pediatric Surgery, Karolinska Institute, St. Göran's Hospital, Stockholm, Sweden.
Eur J Pediatr Surg. 1991 Feb;1(1):15-20. doi: 10.1055/s-2008-1042451.
Extracorporeal membrane oxygenation (ECMO) has rapidly become the treatment of choice for critically ill newborn infants with reversible pulmonary disease refractory to conventional treatment. Since 1987 ECMO has been available at our hospital and up to December 1989 11 patients have been treated. Eight patients could be weaned from ECMO. The aim of this study was to describe the procedure and its implications in the neonatal and pediatric age groups and to present our experience. It is concluded that even though ECMO in the short term is a costly and personnel-consuming procedure it is well documented, safe and life-saving.
体外膜肺氧合（ECMO）已迅速成为患有可逆性肺部疾病且常规治疗无效的危重新生儿的首选治疗方法。自1987年以来，我院已开展ECMO治疗，截至1989年12月，共治疗了11例患者。其中8例患者成功脱离了ECMO。本研究的目的是描述该治疗方法及其在新生儿和儿童年龄组中的应用情况，并介绍我们的经验。研究得出结论，尽管ECMO在短期内是一种成本高昂且耗费人力的治疗方法，但它有充分的文献记载，安全且能挽救生命。
